First biosimilar monoclonal antibody approved in Europe

The Generic Medicines Industry Association has welcomed the announcement from member company, Hospira, that its biosimilar infliximab (Inflectra) is now available in more major European markets, including Austria, Denmark, France, Germany, Greece, Italy, Luxembourg, Netherlands, Spain and Sweden. Inflectra is the first biosimilar monoclonal antibody to be approved in Europe. It provides a more affordable